BIO's BATTLE TO DELETE BREAKTHROUGH DRUGS COUNCIL FROM CLINTON PLAN
Executive Summary
BIO's BATTLE TO DELETE BREAKTHROUGH DRUGS COUNCIL FROM CLINTON PLAN goes to the House Energy & Commerce/Health Subcommittee and Science/Technology Subcommittee during the first two weeks of February as the push to enact health care reform legislation heats up in Congress. Biotechnology Industry Organization President Carl Feldbaum noted at a Jan. 18 "Biotech Tuesday" briefing that the industry association is "focusing now on the Energy & Commerce Committee because they will have [President Clinton's Health Security Act] first, and they will have a significant impact on it."